Cargando…

Consistent defined threshold and equity in health

Detalles Bibliográficos
Autores principales:	Nikfar, Shekoufeh, Babar, Zaheer-Ud-Din, Dinarvand, Rassoul, Kebriaeezadeh, Abbas, Abdollahi, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4334401/ https://www.ncbi.nlm.nih.gov/pubmed/25890072 http://dx.doi.org/10.1186/s40199-015-0097-6

Ejemplares similares

A model for developing a decision support system to simulate national drug policy indicators
por: Abdollahiasl, Akbar, et al.
Publicado: (2011)

A system dynamics model for national drug policy
por: Abdollahiasl, Akbar, et al.
Publicado: (2014)

Cost-effectiveness of different interferon beta products for relapsing-remitting and secondary progressive multiple sclerosis: Decision analysis based on long-term clinical data and switchable treatments
por: Nikfar, Shekoufeh, et al.
Publicado: (2013)

“Annual Pharma Statistics” as a Health Information System Application in Iranian Pharmaceutical Sector
por: Farshchi, Amir, et al.
Publicado: (2015)

Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran
por: Nikfar, Shekoufeh, et al.
Publicado: (2005)

Pharmaceutical supply chain risks: a systematic review
por: Jaberidoost, Mona, et al.
Publicado: (2013)

Assessment of the vaccine industry in Iran in context of accession to WTO: a survey study
por: Hashemi Meshkini, Amir, et al.
Publicado: (2012)

Pharmaceutical market and health system in the Middle Eastern and Central Asian countries: Time for innovations and changes in policies and actions
por: Abdollahias, Akbar, et al.
Publicado: (2011)

A systematic cost-effectiveness analysis of pregabalin in the management of fibromyalgia: an Iranian experience
por: Keshavarz, Khosro, et al.
Publicado: (2013)

Are probiotics effective in management of irritable bowel syndrome?
por: Hosseini, Asieh, et al.
Publicado: (2012)

Current opinion on treatment of inflammatory bowel disease in pregnant women
por: Salari, Pooneh, et al.
Publicado: (2012)

Direct and indirect cost of managing Alzheimer’s disease in the Islamic Republic of Iran
por: Aajami, Zahra, et al.
Publicado: (2019)

The Need for an Evidence-Based Encyclopaedia in Health Services Research in Pharmacy
por: Babar, Zaheer-Ud-Din
Publicado: (2020)

Cost analysis of childhood asthma in Iran: A cost evaluation based on referral center data for asthma and allergies
por: Rezvanfar, Mohammad Ali, et al.
Publicado: (2013)

A review on inputs and outputs in determining the efficiency of universities of medical sciences by data envelopment analysis method
por: Mojahedian, Mohammad M., et al.
Publicado: (2020)

Pharmaceutical supply chain risk assessment in Iran using analytic hierarchy process (AHP) and simple additive weighting (SAW) methods
por: Jaberidoost, Mona, et al.
Publicado: (2015)

Cost-effectiveness analysis review of exemestane in the treatment of primary and advanced breast cancer
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2013)

A Scoping Review of Different Methods of Assessing the Impact of New Medical Technologies at Early Stages of Development
por: Goudarzi, Zahra, et al.
Publicado: (2021)

Evidence based pharmaceutical policy research: Is it all talk or does it contribute to improving health in developing countries?
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2010)

Medicine and the future of health: reflecting on the past to forge ahead
por: Fisher, Dale, et al.
Publicado: (2016)

Medicine and the future of health: reflecting on the past to forge ahead
por: Fisher, Dale, et al.
Publicado: (2016)

Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran
por: Teimouri, Fatemeh, et al.
Publicado: (2017)

Cost-effectiveness of adding-on new antiepileptic drugs to conventional regimens in controlling intractable seizures in children
por: Gharibnaseri, Zahra, et al.
Publicado: (2012)

Mapping the pharmaceutical situation in your country: First things first...
por: Babar, Zaheer-Ud-din, et al.
Publicado: (2009)

Achieving Equitable Access to Medicines and Health Services: A COVID-19-time Recalled Matter
por: Mousavi, Taraneh, et al.
Publicado: (2021)

Medicines and universal health coverage: challenges and opportunities
por: Bigdeli, Maryam, et al.
Publicado: (2015)

Trend analysis of the pharmaceutical market in Iran; 1997–2010; policy implications for developing countries
por: Kebriaeezadeh, Abbas, et al.
Publicado: (2013)

Pharmacists Remuneration Models in Iran and Selected Countries: a Comparative Study
por: Hashemi-Meshkini, Amir, et al.
Publicado: (2013)

“Health supply chain personnel: an integral part of the health workforce.”
por: Cometto, Giorgio, et al.
Publicado: (2014)

Enhanced Oral Delivery of Docetaxel Using Thiolated Chitosan Nanoparticles: Preparation, In Vitro and In Vivo Studies
por: Saremi, Shahrooz, et al.
Publicado: (2013)

Pharmacogenomics Implementation and Hurdles to Overcome; In the Context of a Developing Country
por: Ayati, Nayyereh, et al.
Publicado: (2021)

Ethnicity, Migration and Minority Groups: Medicines Access and Use in High-Income Economies
por: Scahill, Shane, et al.
Publicado: (2012)

Pharmacy practice: Is the gap between the North and South widening?
por: Babar, Zaheer-Ud-din, et al.
Publicado: (2012)

The place of antibiotics in management of irritable bowel syndrome: a systematic review and meta-analysis
por: Rezaie, Ali, et al.
Publicado: (2010)

Efficacy and tolerability of renzapride in irritable bowel syndrome: a meta-analysis of randomized, controlled clinical trials including 2528 patients
por: Mozaffari, Shilan, et al.
Publicado: (2014)

Financial perspective of private pharmacies in Tehran (Iran); is it a lucrative business?
por: Keshavarz, Khosro, et al.
Publicado: (2012)

Southern Med Review to Journal of Pharmaceutical Policy and Practice: broadening the remit!
por: Babar, Zaheer-Ud-Din, et al.
Publicado: (2013)

Pharmacists at the frontline beating the COVID-19 pandemic
por: Bukhari, Nadia, et al.
Publicado: (2020)

Cost-utility of Protocols of BFM-ALL and UK-ALL for Treatment of Children with Acute Lymphoblastic Leukemia in Iran
por: HAYATI, Hadi, et al.
Publicado: (2018)

A step towards gender equity to strengthen the pharmaceutical workforce during COVID-19
por: Bukhari, Nadia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j8et2kcqj0ki4is54qljlsabve